Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is an open-label randomised multicenter clinical study to compare immunogenicity of the drug products Insulin Glargine (Kalbe Farma) and Lantus (Sanofi -Aventis) in type 2 diabetes mellitus patients
Epistemonikos ID: 5428d44744a5af46708b443f7198daba57fd9999
First added on: May 21, 2024